Farallon Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-237,200
| Closed | -$11.7M | – | 117 |
|
|
2015
Q2 | $11.7M | Buy |
237,200
+90,500
| +62% | +$4.48M | 0.16% | 65 |
|
|
2015
Q1 | $11.5M | Sell |
146,700
-47,000
| -24% | -$3.68M | 0.17% | 63 |
|
|
2014
Q4 | $11.7M | Sell |
193,700
-74,730
| -28% | -$4.53M | 0.16% | 59 |
|
|
2014
Q3 | $11.4M | Hold |
268,430
| – | – | 0.18% | 61 |
|
|
2014
Q2 | $16.6M | Hold |
268,430
| – | – | 0.24% | 54 |
|
|
2014
Q1 | $17.4M | Buy |
268,430
+107,930
| +67% | +$7.02M | 0.34% | 50 |
|
|
2013
Q4 | $9.04M | Buy |
160,500
+65,500
| +69% | +$3.69M | 0.19% | 59 |
|
|
2013
Q3 | $5.83M | Hold |
95,000
| – | – | 0.12% | 62 |
|
|
2013
Q2 | $5.56M | Buy |
+95,000
| New | +$5.56M | 0.11% | 62 |
|